Pfizer Inc.
PFEPfizer Inc. (PFE) is a Healthcare company that currently yields 6.18% — trading near fair value based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $24.29 and the overvaluation threshold at $41.62. Pfizer Inc. holds a quality score of 48/100 (Average), reflecting 14 consecutive years of dividend growth. The 5-year dividend CAGR stands at 3.6%.
PFE Dividend Yield History — Weiss Valuation
Distance to undervalued
Waiting for a better entry
Needs about 12.8% downside to reach the Weiss buy zone
Undervaluation starts near $24.29, where the annual dividend would imply roughly 7.08% yield. That is 0.90% above today's yield.
Buy-zone price
$24.29
Target yield
7.08%
Research checklist
What to clear before buying the yield
Updated Oct 8, 2026
Dividend durability
14YLong dividend history supports a deeper look.
Earnings payout
226%Coverage deserves a closer look in filings.
Cash payout
79%Free cash flow coverage supports the payment.
Dividend growth
3.6%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-10-07 → 2026-10-08
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
Pfizer Inc. is trading at a fair valuation relative to its dividend history.
Current yield 6.2% vs historical max 7.0% (88% of maximum).
14 consecutive years without a dividend cut.
Elevated payout ratio of 226%.
What matters now
Read the signal before the headline yield
Valuation is neutral here: quality has to do more of the work than entry price.
The 48/100 quality score says the headline yield needs extra skepticism.
The earnings payout ratio is above 100%, so coverage is the first risk to unpack.
PFE Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$640
Year 10 Income
$1,673
Yield on Cost
18.2%
Total Income
$10,687
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what PFE dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗PFE Dividend Quality Score
Quality Score
Average
Key Metrics
Invest in PFE
Check Pfizer Inc. availability and current costs on eToro
Check eToro terms and availability →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ PFE Dividend Analysis Article